Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

ADHD in Children Health Center

Font Size

New Drug Promises to Help Kids with ADHD

WebMD Health News

Nov. 9, 2001 -- Millions of children in the U.S. take stimulant-based medications like Ritalin to control symptoms of attention deficit hyperactivity disorder (ADHD). The drugs work well, but parents are often uneasy about putting their kids on them. There may soon be another choice, however, if the FDA approves the first non-stimulant treatment specifically targeting the problem.

Newly published studies conducted by manufacturer Eli Lilly and Company (a WebMD sponsor) suggest the drug atomoxetine is both safe and effective in the treatment of children and adolescents with ADHD. The drug not only reduces symptoms associated with the disorder, but children on the drug function better in social and family situations. The manufacturer hopes atomoxetine will gain FDA approval by the latter half of next year.

"What is most exciting is that this drug not only does everything that we would want an ADHD medication to do, but it also has a broad range of impact on functioning that goes beyond treating symptoms traditionally linked to ADHD," Eli Lilly researcher Calvin R. Sumner, MD, tells WebMD.

It is estimated that 3% to 5% of school-age children in the U.S. have ADHD, and as many as 8 million have been prescribed Ritalin or Ritalin-based medications to treat its symptoms. New research suggests Ritalin works by helping to increase the levels of the brain chemical dopamine.

Atomoxetine appears to increase the levels of norepinephrine, another brain chemical believed to be important in regulating the pathways involved in paying attention and controlling impulses.

"Research in the past 20 years has consistently implicated dopamine and norepinephrine as being important chemical messengers in the brain related to the symptoms we see in attention deficit," says Sumner. "To date, the medications have targeted dopamine. We have not had an effective way of impacting norepinephrine."

Researchers conducted an eight-week study of the drug at 13 outpatient treatment sites across the U.S. Approximately 300 children and adolescents with ADHD received either atomoxetine or a placebo. '

Children who took the drug had significantly fewer ADHD symptoms and better social and family functioning than those who did not receive the medication. Side effects were minimal, and 83% of children completed the full eight weeks of treatment.

Today on WebMD

doctor writing on clipboard
mother with child
disciplining a boy
daughter with her unhappy parents
preschool age girl sitting at desk
Child with adhd
father helping son with homework
children in sack race